6VI4
Nanobody-Enabled Monitoring of Kappa Opioid Receptor States
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | APS BEAMLINE 23-ID-D |
| Synchrotron site | APS |
| Beamline | 23-ID-D |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2017-07-01 |
| Detector | DECTRIS EIGER X 16M |
| Wavelength(s) | 1.033 |
| Spacegroup name | P 21 2 21 |
| Unit cell lengths | 102.394, 108.191, 155.100 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 30.010 - 3.300 |
| R-factor | 0.2433 |
| Rwork | 0.242 |
| R-free | 0.27140 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 4djh |
| RMSD bond length | 0.010 |
| RMSD bond angle | 1.344 |
| Data reduction software | HKL-2000 |
| Data scaling software | HKL-2000 |
| Phasing software | PHASER |
| Refinement software | PHENIX (1.17.1_3660) |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 30.013 | 30.000 | 3.390 |
| High resolution limit [Å] | 3.298 | 7.720 | 3.300 |
| Rmerge | 0.182 | 0.059 | 1.114 |
| Rmeas | 0.198 | 0.066 | 1.210 |
| Rpim | 0.075 | 0.027 | 0.454 |
| Number of reflections | 26340 | 2146 | 1998 |
| <I/σ(I)> | 3.6 | ||
| Completeness [%] | 99.1 | 97.7 | 99.2 |
| Redundancy | 6.6 | 6 | 6.6 |
| CC(1/2) | 0.996 | 0.480 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | LIPIDIC CUBIC PHASE | 293 | 100 mM Tris pH 7.0, 360-400 mM Ammonium citrate dibasic, 28-32% PEG400 |






